Absence of MHC class II antigen expression in trophoblast cells results from a lack of class II transactivator (CIITA) gene expression

Molecular Reproduction and Development

Volumn 51, Issue 1, 1998, Pages 1-12

  Murphy, Shawn P ^a   Tomasi, Thomas B ^a,b  

^a ROSWELL PARK CANCER INSTITUTE   (United States)

^b UNIVERSITY AT BUFFALO   (United States)

Author keywords

Class II transactivator (CIITA); MHC class II genes; Transcription; Trophoblast

Indexed keywords

GAMMA INTERFERON; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; MESSENGER RNA; TRANSACTIVATOR PROTEIN;

ANIMAL CELL; ARTICLE; CELL SURFACE; CONTROLLED STUDY; FETUS; GENE EXPRESSION REGULATION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; MOUSE; NONHUMAN; PREGNANCY; PRIORITY JOURNAL; PROMOTER REGION; RAT; TROPHOBLAST;

ANIMALS; CELL LINE; CELL MEMBRANE; GENE EXPRESSION REGULATION, DEVELOPMENTAL; HISTOCOMPATIBILITY ANTIGENS CLASS II; HLA-DR ANTIGENS; HUMANS; INTERFERON TYPE II; MICE; MITOGENS; NUCLEAR PROTEINS; PROMOTER REGIONS (GENETICS); RATS; RNA, MESSENGER; TRANS-ACTIVATORS; TRANSFECTION; TROPHOBLASTS; TUMOR CELLS, CULTURED;

EID: 0031875574     PISSN: 1040452X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1098-2795(199809)51:1<1::AID-MRD1>3.0.CO;2-L     Document Type: Article

References (65)

1. Abdulkadir SA, Ono SJ (1995): How are class II MHC genes turned on and off? FASEB J 9:1429-1435.
2. Albert SE, Strutz F, Shelton K, Haverty T, Sun MJ, Li S, Denham A, Maki RA, Neilson EG (1994): Characterization of a cis-acting regulatory element which silences expression of the class II-A βgene in epithelium. J Exp Med 180: 233-240.
3. Athanassakis-Vassiliadis I, Thanos D, and Papamatheakis J (1989): Induction of class II major histocompatibility complex antigens in murine placenta by 5-azacytidine and interferon-γ involves distinct cell populations. Eur J Immunol 19: 2341-2348.
4. Athanassakis I, Aifantis Y, Makrygiannakis A, Koumantakis E, Vassiliadis S (1995): Placental tissue from human miscarriages expresses class II HLA-DR antigens. Amer J Reprod Immunol 34: 281-287.
5. Baskar S, Ostrand-Rosenberg S, Nabavi N, Nadler LM, Freeman GJ, Glimcher LH (1993): Constitutive expression of B7 restores immunogenicity of tumor cells expressing truncated major histocompatibility complex class II molecules. Proc Natl Acad Sci USA 90: 5687-5690.
6. Basta PV, Sherman PA, Ting JP-Y (1988): Detailed delineation of an interferon-γ-responsive element important in human HLA-DRA gene expression in a glioblastoma multiform line. Proc Natl Acad Sci USA 85:8618-8622.
7. Bateman WJ, Fiera R, Matthews N, Morris AG (1991): Inducibility of class II major histocompatibility antigens by interferon γ is associated with reduced tumorigenicity in C3H mouse fibroblasts transformed by v-Ki-ras. J Exp Med 173:193-196.
8. Benoist C, Mathis D (1990): Regulation of major histocompatibility complex class II genes: X, Y and other letters of the alphabet. Annu Rev Immunol 8:681-715.
9. Boss JM, Strominger JL (1986): Regulation of a transfected human class II major histocompatibility complex gene in human fibroblasts. Proc Natl Acad Sci USA 83:9139-9143.
10. Chalfie M, Tu Y, Euskirchen G, Ward WW, Prasher DC (1994): Green fluorescent protein as a marker for gene expression. Science 263:802-805.
11. Chang C-H, Flavell RA (1995): Class II transactivator regulates the expression of multiple genes involved in antigen presentation. J Exp Med 181:765-767.
12. Chang C-H, Fodor WL, Flavell RA (1992): Reactivation of a major histocompatibility complex class II gene in mouse plasmacytoma cells and mouse T cells. J Exp Med 176:1465-1469.
13. Chang C-H, Fontes JD, Peterlin M, Flavell RA (1994): Class II transactivator (CIITA) is sufficient for the inducible expression of major histocompatibility complex class II genes. J Exp Med 180: 1367-1374.
14. Chang C-H, Guerder S, Hong S-C, van Ewjik W, Flavell RA (1996): Mice lacking the MHC class II transactivator (CIITA) show tissue-specific impairment of MHC class II expression. Immunity 4:167-178.
15. Chatterjee-Hasrouni S, Lala PK (1981): MHC antigens on mouse trophoblast cells: Paucity of Ia antigens despite the presence of H-2K and D. J Immunol 127:2070-2073.
16. Chin K-C, Mao C, Skinner C, Riley JL, Wright KL, Moreno CS, Stark GP, Boss JM, Ting JP-Y (1994): Molecular analysis of G1B and G3A IFNγ mutants reveals that defects in CIITA or RFX result in defective class II MHC and Ii induction. Immunity 1:687-697.
17. Czarniecki CW, Chiu HH, Wong GHW, McCabe SM, Palladino MA (1988): Transforming growth factor-B1 modulates the expression of class II histocompatibility antigens on human cells. J Immunol 140:4217-4223.
18. Dedrick RL, Jones PP (1990): Sequence elements required for activity of a murine major histocompatibility complex class II promoter bind common and cell-type specific factors. Mol Cell Biol 10:593-604.
19. Fontes JD, Jabrane-Ferrat N, Toth CR, Peterlin BM (1996): Binding and cooperative interactions between two B cell-specific transcriptional coactivators. J Exp Med 183:2517-2521.
20. Fuji H, Iribe H (1986): Clonal variation in tumorigenicity of L1210 lymphoma cells: Nontumorigenic variants with an enhanced expression of tumor-associated antigen and Ia antigens. Cancer Research 46:5541-5547.
21. Geiser AG, Letterio JJ, Kulkarni AB, Karlsson S, Roberts AB, Sporn MB (1993): Transforming growth factor β1 (TGFβ1) controls expression of major histocompatibility genes in the postnatal mouse: aberrant histocompatibility antigen expression in the pathogenesis of the TGF-β1 null mouse phenotype. Proc Natl Acad Sci USA 90:9944-9948.
22. Glimcher LH, Kara CJ (1992): Sequences and factors: A guide to MHC class II transcription. Ann Rev Immunol 10:13-49.
23. Gobin SJP, Peijnenburg A, Keijsers V, van den Elsen PJ (1997): Site α is crucial for two routes of IFN-γ-induced MHC class I transactivation: The ISRE-mediated route and a novel pathway involving CIITA. Immunity 6:601-611.
24. Grunstein M (1997): Histone acetylation in chromatin structure and transcription. Nature 389:349-352.
25. Hunt JS, Andrews GK, and Wood GW (1987): Normal trophoblasts resist induction of class I HLA. J Immunol 138:2481-2487.
26. Hunt JS, Atherton RA, Pace JL (1990a): Differential responses of rat trophoblast cells and embryonic fibroblasts to cytokines that regulate proliferation and class I MHC antigen expression. J Immunol 145:184-189.
27. Hunt JS, Deb S, Faria TN, Wheaton D, Soares MJ (1989): Isolation of phenotypically distinct trophoblast cell lines from normal rat chorioallantoic placentas. Placenta 10:161-177.
28. Hunt JS, Fishback JL, Chumbley G. Loke YW (1990b): Identification of class I MHC mRNA in human first trimester trophoblast cells by in situ hybridization. J Immunol 144:4420-4425.
29. Jabrane-Ferrat N, Fontes JD, Boss JM, Peterlin BM (1996): Complex architecture of major histocompatibility complex class II promoters: Reiterated motifs and conserved protein:protein interactions. Mol Cell Biol 16:4683-4690.
30. Kara CJ, Glimcher LH (1993): Promoter accessibility within the environment of the MHC is affected in class II-deficient combined immunodeficiency. EMBO J 12:187-193.
31. Kern I, Steimle V, Siegrist C-A, Mach B (1995): The two novel MHC class II transactivators RFX5 and CIITA both control expression of HLA-DM genes. Internatl Immunol 7:1295-1299.
32. Kohler PO, Bridson WE (1971): Isolation of hormone-producing clonal lines of human choriocarcinoma. J Clin Endocrinol Metab 32:683-687.
33. Lata JA, Tuan RS, Shepley KJ, Mulligan MM, Jackson LG, Smith JB (1992): Localization of major histocompatibility complex class I and II mRNA in human first trimester chorionic villi by in situ hybridization. J Exp Med 175:1027-1032.
34. Latron F, Jotterand-Bellomo M, Maffei A, Scarpellino L, Bernard M, Strominger JL, Acolla RS (1988): Active suppression of major histocompatibility complex class II gene expression during differentiation from B cells to plasma cells. Proc Natl Acad Sci USA 85:2229-2233.
35. Lee Y-J, Benveniste EN (1996): Stat1α expression is involved in IFN-γ induction of the class II transactivator and class II MHC genes. J Immunol 157:1559-1568.
36. Lee Y-J, Han Y, Lu H-T, Nguyen V, Qin H, Howe PH, Hocevar BA, Boss JM, Ransohoff RM, Benveniste EN (1997): TGFβ suppresses IFN-γ induction of class II MHC gene expression by inhibiting class II transactivator messenger RNA expression. J Immunol 158:2065-2075.
37. Lennon A-M, Ottone C, Rigaud G, Deaven LL, Longmire J, Fellous M, Bono R, Alcaide-Loridan C (1997): Isolation of a B-cell-specific promoter for the human class II transactivator. Immunogenetics 45:266-273.
38. Letterio JJ, Geiser AG, Kulkarni AB, Dang H, Kong L, Nakabayashi T, Mackall CL, Gress RE, Roberts AB (1996): Autoimmunity associated with TGF-β1 deficiency in mice is dependent on MHC class II antigen expression. J Clin Invest 98:2109-2119.
39. Mach B, Steimle V, Martinez-Soria E, Reith W (1996): Regulation of MHC class II genes: Lessons from a disease. Ann Rev Immunol 14:301-331.
40. Mahanta SK, Scholl T, Yang F-C, Strominger JL (1997): Transactivation by CIITA, the type II bare lymphocyte syndrome-associated factor, requires participation of multiple regions of the TATA box binding protein. Proc Natl Acad Sci USA 94:6324-6329.
41. Martin BK, Chin K-C, Olson JO, Skinner CA, Dey A, Ozato K, Ting JP-Y (1997): Induction of MHC class I expression by the MHC class II transactivator CIITA. Immunity 6:591-600.
42. Medawar PB (1953): The immunobiology of pregnancy. Symp Soc Exp 44:320-338.
43. Muhlenthaler-Mottet A, Otten LA, Steimle V, Mach B (1997): Expression of MHC class II molecules in different cellular and functional compartments is controlled by differential usage of multiple promoters of the transactivator CIITA. EMBO J 16:2851-2860.
44. Murphy SP, Gollnick SO, Pazmany T, Maier P, Elkin G, Tomasi TB (1997): Repression of MHC class II gene transcription in trophoblast cells by novel single-stranded DNA binding proteins. Mol Reprod Dev 47:390-403.
45. Nandan D, Reiner NE (1997): TGF-Battenuates the class II transactivator and reveals an accessory pathway of IFN-γ action. J Immunol 158:1095-1101.
46. Ostrand-Rosenberg S, Thakur A, Clements V (1990): Rejection of mouse sarcoma cells after transfection of MHC class II genes. J Immunol 144:4068-4071.
47. Pattillo RA, Ruckert A, Hussa R, Bernstein R, Deles E (1971): The JAR cell line - continuous human multi-hormone production and controls. In Vitro 6:398-399.
48. Pazmany T, Murphy SP, Gollnick SO, Brooks SP, Tomasi TB (1995): Activation of multiple transcription factors and fos and jun gene expression in cells exposed to a single electric pulse. Exp Cell Res 221:103-110.
49. Peijnenburg A, Gobin SJP, van Eggermond MCJA, Godthelp BC, van Graafeiland N, van den Elsen PJ (1997): Introduction of exogenous class II trans-activator in MHC class II-deficient ABI fibroblasts results in incomplete rescue of MHC class II antigen expression. J Immunol 159:2720-2727.
50. Peyman JA, Hammond GL (1992): Localization of IFN-γ receptor in first trimester placenta to trophoblasts but lack of stimulation of HLA-DRA, -DRB or invariant chain mRNA expression by IFN-γ. J Immunol 149:2675-2680.
51. Peyman JA, Nelson PJ, Hammond GL (1992): HLA-DR genes are silenced in human trophoblasts and stimulation of signal transduction pathways does not circumvent interferon-γ unresponsiveness. Transplantation Proc 24:470-471.
52. Reimold AM, Kara CJ, Rooney JW, Glimcher LH (1993): Transforming growth factor β1 repression of the HLA-DRα gene is mediated by conserved proximal promoter elements J Immunol 151:4173-4182.
53. Reith W, Siegrist C-A, Durand B, Barras E, Mach B (1994): Function of major histocompatibility complex class II promoters requires cooperative binding between factors RFX and NF-Y. Proc Natl Acad Sci USA 91:554-558.
54. Riley JL, Westerheide SD, Price JA, Brown JA, Boss JM (1995): Activation of class II MHC genes requires both the X box region and the class II transactivator. Immunity 2:533-543.
55. Roby KF, Fei K, Yang Y, Hunt JS (1994): Expression of HLA class I-associated peptide transporter and proteasome genes in human placentas and trophoblast cell lines. Immunology 83:444-448.
56. Sarge KD, Murphy SP, Morimoto RI (1993): Activation of heat shock gene transcription by heat shock factor 1 involves oligomerization, acquisition of DNA-binding activity, and nuclear localization and can occur in the absence of stress. Mol Cell Biol 13:1392-1407.
57. Scholl T, Mahanta SK, Strominger JL (1997): Specific complex formation between the type II bare lymphocyte syndrome-associated transactivators CIITA and RFX5. Proc Natl Acad Sci USA 94:6330-6334.
58. Silacci P, Mottet A, Steimle V, Reith W, Mach B (1994): Developmental extinction of major histocompatibility complex class II gene expression in plasmacytes is mediated by silencing of the transactivator gene CIITA. J Exp Med 180:1329-1336.
59. Steimle V, Otten LA, Zufferey M, Mach B (1993): Complementation cloning of an MHC class II transactivator mutated in hereditary MHC class II deficiency. Cell 75: 135-146.
60. Steimle V, Siegrist C-A, Mottet A, Lisowska.-Grospierre B, Mach B (1994): Regulation of MHC class II expression by interferon-γ mediated by the transactivator gene CIITA. Science 265:106-109.
61. Thanos D, Mavrothalassitis G, Papamatheakis J (1988): Multiple regulatory regions on the 5′ side of the mouse Eα gene. Proc Natl Acad Sci USA 85:3075-3079.
62. Valitutti S, Lanzavecchia A (1997): Serial triggering of TcRs: a basis for the sensitivity and specificity of antigen recognition. Immunol Today 18:299-304.
63. Wolffe AP (1997): Sinful repression. Nature 387:16-17.
64. Zhou H, Glimcher LH (1995): Human MHC class II gene transcription directed by the carboxyl terminus of CIITA, one of the defective genes in type II MHC combined immune deficiency. Immunity 2:545-553.
65. Zuber P, Kuppner MC, de Tribolet N (1988) Transforming growth factor-B2 down-regulates HLA-DR antigen expression on human malignant glioma cells. Eur J Immunol 18:1623-1626.